SIMILAR PATTERNS OF AMINO ACIDS FOR 3LJG_A_HAEA301

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1bud PROTEIN (ACUTOLYSIN
A)

(Deinagkistrodon
acutus) 		PF01421
(Reprolysin) 		5 ILE A 108
HIS A 142
GLU A 143
HIS A 146
HIS A 152
 None
ZN  A 800 (-3.2A)
ZN  A 800 ( 4.7A)
ZN  A 800 (-3.3A)
ZN  A 800 (-3.3A)
 1.38A 3ljgA-1budA:
11.2		 3ljgA-1budA:
22.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1fbl FIBROBLAST
(INTERSTITIAL)
COLLAGENASE (MMP-1)

(Sus scrofa) 		PF00045
(Hemopexin)
PF00413
(Peptidase_M10) 		4 HIS A 218
GLU A 219
HIS A 222
HIS A 228
 ZN  A 998 ( 3.5A)
HTA  A 900 (-3.0A)
ZN  A 998 ( 3.8A)
ZN  A 998 ( 3.6A)
 0.45A 3ljgA-1fblA:
28.1		 3ljgA-1fblA:
37.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1h71 SERRALYSIN

(Pseudomonas sp.
'TAC II 18') 		PF00413
(Peptidase_M10)
PF08548
(Peptidase_M10_C) 		4 HIS P 169
GLU P 170
HIS P 173
HIS P 179
 ZN  P 600 (-3.4A)
ZN  P 600 ( 4.0A)
ZN  P 600 (-3.4A)
ZN  P 600 (-3.4A)
 0.35A 3ljgA-1h71P:
13.0		 3ljgA-1h71P:
17.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hfs STROMELYSIN-1

(Homo sapiens) 		PF00413
(Peptidase_M10) 		4 HIS A 201
GLU A 202
HIS A 205
HIS A 211
 ZN  A 257 ( 3.1A)
L04  A 256 ( 2.7A)
ZN  A 257 ( 3.2A)
ZN  A 257 ( 3.1A)
 0.21A 3ljgA-1hfsA:
30.0		 3ljgA-1hfsA:
58.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1htd ATROLYSIN C

(Crotalus atrox) 		PF01421
(Reprolysin) 		4 HIS A 142
GLU A 143
HIS A 146
HIS A 152
 ZN  A 401 ( 3.2A)
ZN  A 401 ( 4.5A)
ZN  A 401 ( 3.2A)
ZN  A 401 ( 3.2A)
 0.21A 3ljgA-1htdA:
11.5		 3ljgA-1htdA:
24.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hv5 STROMELYSIN 3

(Mus musculus) 		PF00413
(Peptidase_M10) 		5 ILE A 180
HIS A 219
GLU A 220
HIS A 223
HIS A 229
 RXP  A6001 ( 3.8A)
ZN  A5502 ( 3.4A)
RXP  A6001 (-3.0A)
ZN  A5502 (-3.4A)
ZN  A5502 (-3.5A)
 0.50A 3ljgA-1hv5A:
24.1		 3ljgA-1hv5A:
49.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1iab ASTACIN

(Astacus astacus) 		PF01400
(Astacin) 		4 HIS A  92
GLU A  93
HIS A  96
HIS A 102
 CO  A 999 (-3.2A)
CO  A 999 ( 4.3A)
CO  A 999 (-3.3A)
CO  A 999 (-3.1A)
 0.30A 3ljgA-1iabA:
10.7		 3ljgA-1iabA:
21.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1kcw CERULOPLASMIN

(Homo sapiens) 		PF00394
(Cu-oxidase)
PF07731
(Cu-oxidase_2)
PF07732
(Cu-oxidase_3) 		4 ILE A 159
HIS A 163
HIS A 980
HIS A1020
 None
CU  A1050 (-3.3A)
CU  A1050 (-3.0A)
CU  A1050 (-3.2A)
 0.98A 3ljgA-1kcwA:
undetectable		 3ljgA-1kcwA:
9.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1kug METALLOPROTEINASE

(Protobothrops
mucrosquamatus) 		PF01421
(Reprolysin) 		4 HIS A 144
GLU A 145
HIS A 148
HIS A 154
 CD  A 981 (-3.5A)
CD  A 981 ( 4.6A)
CD  A 981 (-3.4A)
CD  A 981 (-3.4A)
 0.18A 3ljgA-1kugA:
11.2		 3ljgA-1kugA:
23.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1l6j MATRIX
METALLOPROTEINASE-9

(Homo sapiens) 		PF00040
(fn2)
PF00413
(Peptidase_M10)
PF01471
(PG_binding_1) 		4 HIS A 401
GLU A 402
HIS A 405
HIS A 411
 ZN  A 500 (-3.4A)
ZN  A 500 ( 4.3A)
ZN  A 500 (-3.2A)
ZN  A 500 (-3.4A)
 0.25A 3ljgA-1l6jA:
25.0		 3ljgA-1l6jA:
23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1lml LEISHMANOLYSIN

(Leishmania
major) 		PF01457
(Peptidase_M8) 		4 HIS A 264
GLU A 265
HIS A 268
HIS A 334
 ZN  A 578 ( 3.5A)
ZN  A 578 ( 4.1A)
ZN  A 578 ( 3.4A)
ZN  A 578 ( 3.4A)
 0.44A 3ljgA-1lmlA:
8.3		 3ljgA-1lmlA:
16.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nd1 BAP1

(Bothrops asper) 		PF01421
(Reprolysin) 		4 HIS A 142
GLU A 143
HIS A 146
HIS A 152
 ZN  A 400 (-3.2A)
ZN  A 400 ( 4.4A)
ZN  A 400 (-3.3A)
ZN  A 400 (-3.2A)
 0.10A 3ljgA-1nd1A:
11.4		 3ljgA-1nd1A:
24.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1pss PHOTOSYNTHETIC
REACTION CENTER

(Rhodobacter
sphaeroides) 		PF00124
(Photo_RC) 		4 ILE M 238
HIS M 219
HIS L 190
HIS L 230
 None
FE  M 302 ( 3.3A)
FE  M 302 ( 3.3A)
FE  M 302 (-3.4A)
 0.91A 3ljgA-1pssM:
undetectable		 3ljgA-1pssM:
18.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1qib 72 KDA TYPE IV
COLLAGENASE

(Homo sapiens) 		PF00413
(Peptidase_M10) 		4 HIS A 201
GLU A 202
HIS A 205
HIS A 211
 ZN  A 501 (-3.5A)
ZN  A 501 ( 4.5A)
ZN  A 501 (-3.5A)
ZN  A 501 (-3.5A)
 0.30A 3ljgA-1qibA:
27.7		 3ljgA-1qibA:
59.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qua ACUTOLYSIN-C

(Deinagkistrodon
acutus) 		PF01421
(Reprolysin) 		4 HIS A 142
GLU A 143
HIS A 146
HIS A 152
 ZN  A 999 (-3.2A)
ZN  A 999 ( 4.5A)
ZN  A 999 (-3.3A)
ZN  A 999 (-3.1A)
 0.13A 3ljgA-1quaA:
11.4		 3ljgA-1quaA:
23.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1r55 ADAM 33

(Homo sapiens) 		PF01421
(Reprolysin) 		4 HIS A 345
GLU A 346
HIS A 349
HIS A 355
 ZN  A 201 ( 3.3A)
097  A 518 (-2.9A)
ZN  A 201 ( 3.2A)
ZN  A 201 ( 3.3A)
 0.28A 3ljgA-1r55A:
10.4		 3ljgA-1r55A:
25.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1rm8 MATRIX
METALLOPROTEINASE-16

(Homo sapiens) 		PF00413
(Peptidase_M10) 		4 HIS A 246
GLU A 247
HIS A 250
HIS A 256
 ZN  A 500 ( 3.3A)
BAT  A 800 (-2.7A)
ZN  A 500 ( 3.2A)
ZN  A 500 ( 3.3A)
 0.21A 3ljgA-1rm8A:
28.0		 3ljgA-1rm8A:
50.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1slm STROMELYSIN-1

(Homo sapiens) 		PF00413
(Peptidase_M10)
PF01471
(PG_binding_1) 		4 HIS A 201
GLU A 202
HIS A 205
HIS A 211
 ZN  A 257 ( 3.0A)
ZN  A 257 ( 4.1A)
ZN  A 257 ( 3.2A)
ZN  A 257 ( 3.1A)
 0.27A 3ljgA-1slmA:
28.7		 3ljgA-1slmA:
41.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vm6 DIHYDRODIPICOLINATE
REDUCTASE

(Thermotoga
maritima) 		PF01113
(DapB_N)
PF05173
(DapB_C) 		4 ILE A 140
HIS A 164
GLU A 125
HIS A 127
 None
None
None
ACT  A 217 (-4.2A)
 0.97A 3ljgA-1vm6A:
2.8		 3ljgA-1vm6A:
22.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1wni TRIMERELYSIN II

(Protobothrops
flavoviridis) 		PF01421
(Reprolysin) 		5 ILE A 108
HIS A 142
GLU A 143
HIS A 146
HIS A 152
 None
ZN  A 999 (-3.5A)
ZN  A 999 ( 4.2A)
ZN  A 999 (-3.5A)
ZN  A 999 (-3.4A)
 1.49A 3ljgA-1wniA:
11.3		 3ljgA-1wniA:
19.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xcr HYPOTHETICAL PROTEIN
PTD012

(Homo sapiens) 		PF08925
(DUF1907) 		4 HIS A 268
GLU A 110
HIS A 278
HIS A 266
 ZN  A1001 ( 3.2A)
ACY  A2001 ( 3.7A)
ZN  A1001 ( 3.2A)
ZN  A1001 ( 3.2A)
 0.93A 3ljgA-1xcrA:
undetectable		 3ljgA-1xcrA:
21.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xv2 HYPOTHETICAL
PROTEIN, SIMILAR TO
ALPHA-ACETOLACTATE
DECARBOXYLASE

(Staphylococcus
aureus) 		PF03306
(AAL_decarboxy) 		4 HIS A 175
GLU A  45
HIS A 186
HIS A 173
 ZN  A 801 (-3.4A)
ZN  A 801 ( 4.4A)
ZN  A 801 (-3.3A)
ZN  A 801 (-3.5A)
 0.71A 3ljgA-1xv2A:
undetectable		 3ljgA-1xv2A:
19.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1y13 6-PYRUVOYL
TETRAHYDROPTERIN
SYNTHASE

(Plasmodium
falciparum) 		PF01242
(PTPS) 		4 HIS A  41
GLU A  38
HIS A  29
HIS A  43
 ZN  A 174 ( 3.3A)
BIO  A 175 (-2.6A)
ZN  A 174 ( 3.5A)
ZN  A 174 ( 3.4A)
 0.90A 3ljgA-1y13A:
undetectable		 3ljgA-1y13A:
18.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1y9q TRANSCRIPTIONAL
REGULATOR, HTH_3
FAMILY

(Vibrio cholerae) 		PF01381
(HTH_3) 		4 ILE A 109
HIS A 162
GLU A 128
HIS A 122
 None
ZN  A 202 ( 3.4A)
ZN  A 202 ( 2.5A)
ZN  A 202 ( 3.3A)
 0.95A 3ljgA-1y9qA:
undetectable		 3ljgA-1y9qA:
22.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1yp1 FII

(Deinagkistrodon
acutus) 		PF01421
(Reprolysin) 		4 HIS A 142
GLU A 143
HIS A 146
HIS A 152
 ZN  A 999 (-3.3A)
ZN  A 999 ( 4.9A)
ZN  A 999 (-3.4A)
ZN  A 999 (-3.2A)
 0.27A 3ljgA-1yp1A:
11.5		 3ljgA-1yp1A:
21.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zoi ESTERASE

(Pseudomonas
putida) 		PF00561
(Abhydrolase_1) 		4 ILE A  12
GLU A 102
HIS A  28
HIS A  26
 None
 1.03A 3ljgA-1zoiA:
2.1		 3ljgA-1zoiA:
20.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2a0s 6-PYRUVOYL
TETRAHYDROPTERIN
SYNTHASE

(Plasmodium
vivax) 		PF01242
(PTPS) 		4 HIS A  48
GLU A  45
HIS A  36
HIS A  50
 ZN  A 281 (-3.3A)
BIO  A 282 (-3.1A)
ZN  A 281 ( 3.5A)
ZN  A 281 (-3.3A)
 0.89A 3ljgA-2a0sA:
undetectable		 3ljgA-2a0sA:
21.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2awc HEMERYTHRIN-LIKE
DOMAIN PROTEIN DCRH

(Desulfovibrio
vulgaris) 		PF01814
(Hemerythrin) 		4 ILE A  19
HIS A  82
HIS A 118
HIS A  78
 None
FEO  A 137 (-3.3A)
FEO  A 137 (-3.3A)
FEO  A 137 (-3.5A)
 0.98A 3ljgA-2awcA:
undetectable		 3ljgA-2awcA:
21.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dw1 CATROCOLLASTATIN

(Crotalus atrox) 		PF00200
(Disintegrin)
PF01421
(Reprolysin)
PF08516
(ADAM_CR) 		5 ILE A 299
HIS A 333
GLU A 334
HIS A 337
HIS A 343
 GM6  A   2 (-3.6A)
ZN  A 700 ( 3.4A)
GM6  A   2 (-2.5A)
ZN  A 700 ( 3.2A)
ZN  A 700 ( 3.2A)
 1.40A 3ljgA-2dw1A:
10.6		 3ljgA-2dw1A:
15.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2e3x COAGULATION FACTOR
X-ACTIVATING ENZYME
HEAVY CHAIN

(Daboia
siamensis) 		PF00200
(Disintegrin)
PF01421
(Reprolysin)
PF08516
(ADAM_CR) 		4 HIS A 145
GLU A 146
HIS A 149
HIS A 155
 ZN  A 800 ( 3.3A)
GM6  A 700 ( 3.4A)
ZN  A 800 ( 3.2A)
ZN  A 800 ( 3.1A)
 0.27A 3ljgA-2e3xA:
10.6		 3ljgA-2e3xA:
16.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2erq VASCULAR
APOPTOSIS-INDUCING
PROTEIN 1

(Crotalus atrox) 		PF00200
(Disintegrin)
PF01421
(Reprolysin)
PF08516
(ADAM_CR) 		4 HIS A 335
GLU A 336
HIS A 339
HIS A 345
 ZN  A 700 (-3.4A)
ZN  A 700 ( 4.3A)
ZN  A 700 (-3.4A)
ZN  A 700 (-3.0A)
 0.17A 3ljgA-2erqA:
10.1		 3ljgA-2erqA:
17.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fv5 ADAM 17

(Homo sapiens) 		PF13688
(Reprolysin_5) 		4 HIS A 405
GLU A 406
HIS A 409
HIS A 415
 ZN  A   3 ( 3.2A)
541  A   1 (-2.6A)
ZN  A   3 ( 3.3A)
ZN  A   3 ( 3.2A)
 0.26A 3ljgA-2fv5A:
10.0		 3ljgA-2fv5A:
23.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2jsd MATRIX
METALLOPROTEINASE-20

(Homo sapiens) 		PF00413
(Peptidase_M10) 		4 HIS A 226
GLU A 227
HIS A 230
HIS A 236
 NGH  A 277 ( 3.0A)
NGH  A 277 (-3.6A)
ZN  A 276 ( 3.3A)
ZN  A 276 ( 3.0A)
 0.64A 3ljgA-2jsdA:
25.3		 3ljgA-2jsdA:
54.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2oy4 NEUTROPHIL
COLLAGENASE

(Homo sapiens) 		PF00413
(Peptidase_M10) 		5 ILE A 159
HIS A 197
GLU A 198
HIS A 201
HIS A 207
 None
ZN  A 999 (-3.2A)
ZN  A 999 ( 4.4A)
ZN  A 999 (-3.4A)
ZN  A 999 (-3.2A)
 0.29A 3ljgA-2oy4A:
29.4		 3ljgA-2oy4A:
53.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2rjq ADAMTS-5

(Homo sapiens) 		PF01421
(Reprolysin) 		4 HIS A 410
GLU A 411
HIS A 414
HIS A 420
 ZN  A   1 ( 3.2A)
BAT  A 559 (-2.5A)
ZN  A   1 ( 3.3A)
ZN  A   1 ( 3.3A)
 0.18A 3ljgA-2rjqA:
10.7		 3ljgA-2rjqA:
15.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2x7m ARCHAEMETZINCIN

(Methanopyrus
kandleri) 		PF07998
(Peptidase_M54) 		4 HIS A 125
GLU A 126
HIS A 129
HIS A 135
 ZN  A1174 (-3.2A)
ZN  A1174 ( 4.2A)
ZN  A1174 (-3.2A)
ZN  A1174 (-3.2A)
 0.21A 3ljgA-2x7mA:
10.6		 3ljgA-2x7mA:
23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2y0o PROBABLE D-LYXOSE
KETOL-ISOMERASE

(Bacillus
subtilis) 		no annotation 4 HIS A 137
GLU A  82
HIS A  71
HIS A  69
 ZN  A1173 (-3.4A)
ZN  A1173 (-2.6A)
ZN  A1173 (-3.4A)
ZN  A1173 (-3.6A)
 1.02A 3ljgA-2y0oA:
undetectable		 3ljgA-2y0oA:
19.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2y6c MATRILYSIN

(Homo sapiens) 		PF00413
(Peptidase_M10) 		4 HIS A 219
GLU A 220
HIS A 223
HIS A 229
 ZN  A1267 ( 3.2A)
TQI  A1269 (-2.9A)
ZN  A1267 ( 3.3A)
ZN  A1267 ( 3.2A)
 0.20A 3ljgA-2y6cA:
26.3		 3ljgA-2y6cA:
53.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2yb4 AMIDOHYDROLASE

(Chromobacterium
violaceum) 		PF02811
(PHP) 		4 ILE A  76
HIS A   7
GLU A 218
HIS A 191
 None
 0.99A 3ljgA-2yb4A:
undetectable		 3ljgA-2yb4A:
20.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3b8z PROTEIN ADAMTS-5

(Homo sapiens) 		PF01421
(Reprolysin) 		4 HIS A 410
GLU A 411
HIS A 414
HIS A 420
 ZN  A 901 ( 3.2A)
294  A 801 (-2.7A)
ZN  A 901 ( 3.3A)
ZN  A 901 ( 3.3A)
 0.13A 3ljgA-3b8zA:
10.9		 3ljgA-3b8zA:
23.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ba0 MACROPHAGE
METALLOELASTASE

(Homo sapiens) 		PF00045
(Hemopexin)
PF00413
(Peptidase_M10) 		5 ILE A 180
HIS A 218
GLU A 219
HIS A 222
HIS A 228
 None
ZN  A 471 (-4.0A)
ZN  A 471 ( 3.2A)
HAE  A 477 ( 3.1A)
ZN  A 471 (-3.7A)
 0.65A 3ljgA-3ba0A:
28.3		 3ljgA-3ba0A:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3cny INOSITOL CATABOLISM
PROTEIN IOLE

(Lactobacillus
plantarum) 		PF01261
(AP_endonuc_2) 		4 ILE A  16
HIS A 159
HIS A 161
HIS A 192
 None
 0.96A 3ljgA-3cnyA:
undetectable		 3ljgA-3cnyA:
19.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dsl ZINC
METALLOPROTEINASE-DI
SINTEGRIN
BOTHROPASIN

(Bothrops
jararaca) 		PF00200
(Disintegrin)
PF01421
(Reprolysin)
PF08516
(ADAM_CR) 		5 ILE A 111
HIS A 145
GLU A 146
HIS A 149
HIS A 155
 FLE  A 504 (-3.9A)
ZN  A 503 ( 3.3A)
TRP  A 505 (-2.4A)
ZN  A 503 ( 3.3A)
ZN  A 503 ( 3.3A)
 1.27A 3ljgA-3dslA:
10.2		 3ljgA-3dslA:
16.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3edi TOLLOID-LIKE PROTEIN
1

(Homo sapiens) 		PF01400
(Astacin) 		4 HIS A  92
GLU A  93
HIS A  96
HIS A 102
 ZN  A 210 (-3.2A)
ZN  A 210 ( 4.3A)
ZN  A 210 (-3.3A)
ZN  A 210 (-3.2A)
 0.19A 3ljgA-3ediA:
10.3		 3ljgA-3ediA:
23.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gbo ZINC
METALLOPROTEINASE
BMOOMPALFA-I

(Bothrops
moojeni) 		PF01421
(Reprolysin) 		5 ILE A 106
HIS A 140
GLU A 141
HIS A 144
HIS A 150
 None
ZN  A 302 (-3.3A)
ZN  A 302 ( 4.6A)
ZN  A 302 (-3.3A)
ZN  A 302 (-3.2A)
 1.41A 3ljgA-3gboA:
11.1		 3ljgA-3gboA:
24.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hdb AAHIV

(Deinagkistrodon
acutus) 		PF00200
(Disintegrin)
PF01421
(Reprolysin)
PF08516
(ADAM_CR) 		5 ILE A 298
HIS A 333
GLU A 334
HIS A 337
HIS A 343
 None
ZN  A 620 (-3.4A)
ZN  A 620 ( 4.2A)
ZN  A 620 (-3.3A)
ZN  A 620 (-3.1A)
 0.35A 3ljgA-3hdbA:
10.6		 3ljgA-3hdbA:
17.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hdb AAHIV

(Deinagkistrodon
acutus) 		PF00200
(Disintegrin)
PF01421
(Reprolysin)
PF08516
(ADAM_CR) 		5 ILE A 299
HIS A 333
GLU A 334
HIS A 337
HIS A 343
 None
ZN  A 620 (-3.4A)
ZN  A 620 ( 4.2A)
ZN  A 620 (-3.3A)
ZN  A 620 (-3.1A)
 1.46A 3ljgA-3hdbA:
10.6		 3ljgA-3hdbA:
17.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3k7n K-LIKE

(Naja atra) 		PF01421
(Reprolysin)
PF08516
(ADAM_CR) 		4 HIS A 341
GLU A 342
HIS A 345
HIS A 351
 ZN  A 704 (-3.1A)
ZN  A 704 ( 4.5A)
ZN  A 704 (-3.3A)
ZN  A 704 (-3.2A)
 0.23A 3ljgA-3k7nA:
10.8		 3ljgA-3k7nA:
18.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kmh D-LYXOSE ISOMERASE

(Escherichia
coli) 		PF07385
(Lyx_isomer) 		4 HIS A 171
GLU A 110
HIS A 105
HIS A 103
 MN  A1001 (-3.3A)
MN  A1001 (-2.6A)
MN  A1001 (-3.2A)
MN  A1001 (-3.6A)
 1.01A 3ljgA-3kmhA:
undetectable		 3ljgA-3kmhA:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lmc PEPTIDASE,
ZINC-DEPENDENT

(Methanocorpusculum
labreanum) 		PF07998
(Peptidase_M54) 		4 HIS A 149
GLU A 150
HIS A 153
HIS A 159
 ZN  A 212 (-3.4A)
ZN  A 212 ( 4.3A)
ZN  A 212 (-3.4A)
ZN  A 212 (-3.3A)
 0.25A 3ljgA-3lmcA:
5.8		 3ljgA-3lmcA:
24.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lqb LOC792177 PROTEIN

(Danio rerio) 		PF01400
(Astacin) 		4 HIS A  99
GLU A 100
HIS A 103
HIS A 109
 ZN  A 201 ( 3.2A)
SO4  A 200 (-3.0A)
ZN  A 201 ( 3.3A)
ZN  A 201 ( 3.2A)
 0.30A 3ljgA-3lqbA:
10.6		 3ljgA-3lqbA:
22.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lun ULILYSIN

(Methanosarcina
acetivorans) 		PF05572
(Peptidase_M43) 		5 ILE A 187
HIS A 228
GLU A 229
HIS A 232
HIS A 238
 None
ZN  A 999 (-3.1A)
ZN  A 999 ( 3.8A)
ZN  A 999 (-3.1A)
ZN  A 999 (-3.0A)
 0.51A 3ljgA-3lunA:
8.6		 3ljgA-3lunA:
23.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3o14 ANTI-ECFSIGMA
FACTOR, CHRR

(Marinobacter
hydrocarbonoclasticus) 		PF12973
(Cupin_7) 		4 ILE A 104
HIS A  60
HIS A  58
HIS A  94
 None
ZN  A 250 (-3.3A)
ZN  A 250 (-3.3A)
ZN  A 250 (-3.3A)
 0.85A 3ljgA-3o14A:
undetectable		 3ljgA-3o14A:
20.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3o14 ANTI-ECFSIGMA
FACTOR, CHRR

(Marinobacter
hydrocarbonoclasticus) 		PF12973
(Cupin_7) 		4 ILE A 104
HIS A  94
HIS A  60
HIS A  58
 None
ZN  A 250 (-3.3A)
ZN  A 250 (-3.3A)
ZN  A 250 (-3.3A)
 1.02A 3ljgA-3o14A:
undetectable		 3ljgA-3o14A:
20.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3o2x COLLAGENASE 3

(Homo sapiens) 		PF00413
(Peptidase_M10) 		4 HIS A1222
GLU A1223
HIS A1226
HIS A1232
 ZN  A1999 ( 3.2A)
3O2  A1801 (-2.7A)
ZN  A1999 ( 3.4A)
ZN  A1999 ( 3.2A)
 0.26A 3ljgA-3o2xA:
29.0		 3ljgA-3o2xA:
56.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3p24 BFT-3

(Bacteroides
fragilis) 		PF13583
(Reprolysin_4)
PF16376
(fragilysinNterm) 		5 ILE A 313
HIS A 348
GLU A 349
HIS A 352
HIS A 358
 None
ZN  A 999 (-3.2A)
ZN  A 999 ( 4.9A)
ZN  A 999 (-3.2A)
ZN  A 999 ( 3.2A)
 0.38A 3ljgA-3p24A:
8.9		 3ljgA-3p24A:
18.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3q2h A DISINTEGRIN AND
METALLOPROTEINASE
WITH THROMBOSPONDIN
MOTIFS 1

(Homo sapiens) 		PF01421
(Reprolysin) 		4 HIS A 149
GLU A 150
HIS A 153
HIS A 159
 ZN  A 401 ( 3.3A)
QHF  A   1 (-2.6A)
QHF  A   1 ( 3.0A)
ZN  A 401 ( 3.2A)
 0.21A 3ljgA-3q2hA:
10.8		 3ljgA-3q2hA:
18.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3rde ARACHIDONATE
12-LIPOXYGENASE,
12S-TYPE

(Sus scrofa) 		PF00305
(Lipoxygenase) 		4 ILE A 593
GLU A 357
HIS A 361
HIS A 545
 OYP  A 664 (-4.3A)
OYP  A 664 (-3.6A)
FE2  A   1 ( 3.4A)
FE2  A   1 (-3.3A)
 0.69A 3ljgA-3rdeA:
undetectable		 3ljgA-3rdeA:
15.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3rys ADENOSINE DEAMINASE
1

(Paenarthrobacter
aurescens) 		PF00962
(A_deaminase) 		4 ILE A 139
HIS A  21
HIS A  19
HIS A 199
 None
ADE  A 345 ( 3.2A)
ZN  A 344 (-3.5A)
ZN  A 344 ( 3.4A)
 0.97A 3ljgA-3rysA:
undetectable		 3ljgA-3rysA:
19.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3shi INTERSTITIAL
COLLAGENASE

(Homo sapiens) 		PF00413
(Peptidase_M10) 		4 HIS A 218
GLU A 219
HIS A 222
HIS A 228
 ZN  A 301 (-3.3A)
ZN  A 301 ( 4.7A)
ZN  A 301 (-3.4A)
ZN  A 301 (-3.3A)
 0.26A 3ljgA-3shiA:
30.1		 3ljgA-3shiA:
57.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3u43 COLICIN-E2

(Escherichia
coli) 		no annotation 4 ILE B 107
HIS B 102
HIS B 127
HIS B 131
 None
ZN  B 135 (-3.2A)
ZN  B 135 (-3.3A)
ZN  B 135 (-3.4A)
 0.99A 3ljgA-3u43B:
undetectable		 3ljgA-3u43B:
21.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3v96 STROMELYSIN-2

(Homo sapiens) 		PF00413
(Peptidase_M10) 		4 HIS B 217
GLU B 218
HIS B 221
HIS B 227
 ZN  B 301 (-3.2A)
ZN  B 301 ( 3.9A)
ZN  B 301 (-3.3A)
ZN  B 301 (-3.2A)
 0.32A 3ljgA-3v96B:
29.9		 3ljgA-3v96B:
55.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3vi1 ALKALINE
METALLOPROTEINASE

(Pseudomonas
aeruginosa) 		PF08548
(Peptidase_M10_C)
PF13583
(Reprolysin_4) 		4 HIS A 176
GLU A 177
HIS A 180
HIS A 186
 ZN  A 500 (-3.2A)
ZN  A 500 ( 4.2A)
ZN  A 500 (-3.3A)
ZN  A 500 (-3.2A)
 0.23A 3ljgA-3vi1A:
13.2		 3ljgA-3vi1A:
16.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3vtg HIGH CHORIOLYTIC
ENZYME 1

(Oryzias latipes) 		PF01400
(Astacin) 		4 HIS A  99
GLU A 100
HIS A 103
HIS A 109
 ZN  A 301 (-3.3A)
ZN  A 301 ( 4.3A)
ZN  A 301 (-3.3A)
ZN  A 301 (-3.2A)
 0.21A 3ljgA-3vtgA:
10.5		 3ljgA-3vtgA:
22.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4a3w ARCHAEMETZINCIN

(Archaeoglobus
fulgidus) 		PF07998
(Peptidase_M54) 		4 HIS A 117
GLU A 118
HIS A 121
HIS A 127
 ZN  A1159 ( 3.2A)
FLC  A1161 (-2.9A)
ZN  A1159 ( 3.3A)
ZN  A1159 ( 3.2A)
 0.30A 3ljgA-4a3wA:
8.2		 3ljgA-4a3wA:
26.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4aig ADAMALYSIN II

(Crotalus
adamanteus) 		PF01421
(Reprolysin) 		5 ILE A 107
HIS A 142
GLU A 143
HIS A 146
HIS A 152
 FLX  A 400 (-3.9A)
ZN  A 999 ( 3.2A)
FLX  A 400 (-2.8A)
ZN  A 999 ( 3.3A)
ZN  A 999 ( 3.5A)
 0.56A 3ljgA-4aigA:
11.4		 3ljgA-4aigA:
27.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4aig ADAMALYSIN II

(Crotalus
adamanteus) 		PF01421
(Reprolysin) 		5 ILE A 108
HIS A 142
GLU A 143
HIS A 146
HIS A 152
 FLX  A 400 (-4.3A)
ZN  A 999 ( 3.2A)
FLX  A 400 (-2.8A)
ZN  A 999 ( 3.3A)
ZN  A 999 ( 3.5A)
 1.48A 3ljgA-4aigA:
11.4		 3ljgA-4aigA:
27.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bpt PHENYLALANINE-4-HYDR
OXYLASE (PAH)
(PHE-4-MONOOXYGENASE
)

(Legionella
pneumophila) 		PF00351
(Biopterin_H) 		4 ILE A  86
HIS A 122
GLU A 123
HIS A 127
 None
 0.97A 3ljgA-4bptA:
undetectable		 3ljgA-4bptA:
20.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bt6 ALPHA-ACETOLACTATE
DECARBOXYLASE

(Brevibacillus
brevis) 		PF03306
(AAL_decarboxy) 		4 HIS A 196
GLU A  65
HIS A 207
HIS A 194
 ZN  A1257 ( 3.3A)
GOL  A1258 (-2.7A)
ZN  A1257 ( 3.2A)
ZN  A1257 ( 3.3A)
 0.78A 3ljgA-4bt6A:
undetectable		 3ljgA-4bt6A:
20.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4dd8 DISINTEGRIN AND
METALLOPROTEINASE
DOMAIN-CONTAINING
PROTEIN 8

(Homo sapiens) 		PF01421
(Reprolysin) 		4 HIS A 334
GLU A 335
HIS A 338
HIS A 344
 ZN  A1002 ( 3.3A)
BAT  A1000 (-2.7A)
ZN  A1002 (-3.3A)
ZN  A1002 ( 3.3A)
 0.41A 3ljgA-4dd8A:
10.5		 3ljgA-4dd8A:
18.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4gr8 MACROPHAGE
METALLOELASTASE

(Homo sapiens) 		PF00413
(Peptidase_M10) 		5 ILE A 180
HIS A 218
GLU A 219
HIS A 222
HIS A 228
 R4C  A 306 (-4.3A)
R4C  A 306 ( 3.2A)
R4C  A 306 (-2.7A)
ZN  A 301 ( 3.2A)
ZN  A 301 ( 3.2A)
 0.44A 3ljgA-4gr8A:
30.3		 3ljgA-4gr8A:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gwn MEPRIN A SUBUNIT
BETA

(Homo sapiens) 		PF00629
(MAM)
PF01400
(Astacin) 		4 HIS A 152
GLU A 153
HIS A 156
HIS A 162
 CD  A 701 (-3.7A)
CD  A 701 (-3.5A)
CD  A 701 (-3.7A)
CD  A 701 (-3.7A)
 0.32A 3ljgA-4gwnA:
9.5		 3ljgA-4gwnA:
13.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4in9 KARILYSIN PROTEASE

(Tannerella
forsythia) 		PF00413
(Peptidase_M10) 		5 ILE A 114
HIS A 155
GLU A 156
HIS A 159
HIS A 165
 None
ZN  A 301 (-3.2A)
ZN  A 301 ( 4.2A)
ZN  A 301 (-3.3A)
ZN  A 301 (-3.3A)
 0.80A 3ljgA-4in9A:
24.0		 3ljgA-4in9A:
39.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4j3q CATECHOL OXIDASE

(Aspergillus
oryzae) 		PF00264
(Tyrosinase) 		4 ILE A 109
HIS A 284
HIS A 288
HIS A 312
 None
CU  A1002 (-3.2A)
CU  A1002 (-3.2A)
CU  A1002 (-3.2A)
 1.01A 3ljgA-4j3qA:
undetectable		 3ljgA-4j3qA:
18.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4j4m ZINC-DEPENDENT
METALLOPROTEINASE

(Protobothrops
mucrosquamatus) 		PF01421
(Reprolysin) 		4 HIS A 144
GLU A 145
HIS A 148
HIS A 154
 ZN  A 301 (-3.3A)
ZN  A 301 ( 4.6A)
ZN  A 301 (-3.2A)
ZN  A 301 (-3.2A)
 0.12A 3ljgA-4j4mA:
11.3		 3ljgA-4j4mA:
23.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jiu PROABYLYSIN

(Pyrococcus
abyssi) 		PF01863
(DUF45) 		4 HIS A  60
GLU A  61
HIS A  64
HIS A  72
 ZN  A 201 (-3.2A)
ZN  A 201 ( 4.8A)
ZN  A 201 (-3.2A)
ZN  A 201 (-3.2A)
 0.31A 3ljgA-4jiuA:
4.7		 3ljgA-4jiuA:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jix PROJANNALYSIN

(Methanocaldococcus
jannaschii) 		PF01863
(DUF45) 		4 HIS A  69
GLU A  70
HIS A  73
HIS A  81
 ZN  A 201 (-3.3A)
TRS  A 202 (-3.8A)
ZN  A 201 ( 3.3A)
ZN  A 201 (-3.3A)
 0.50A 3ljgA-4jixA:
4.7		 3ljgA-4jixA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4l63 ECXA

(Escherichia
coli) 		PF16313
(DUF4953) 		4 HIS A 179
GLU A 180
HIS A 183
HIS A 189
 ZN  A 301 (-3.3A)
ZN  A 301 ( 4.4A)
ZN  A 301 (-3.4A)
ZN  A 301 (-3.3A)
 0.16A 3ljgA-4l63A:
12.0		 3ljgA-4l63A:
22.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4q1l SNAKE VENOM
METALLOPROTEINASE
LEUCUROLYSIN-A

(Bothrops
leucurus) 		PF01421
(Reprolysin) 		4 HIS A 142
GLU A 143
HIS A 146
HIS A 152
 ZN  A 302 (-3.2A)
ZN  A 302 ( 4.7A)
ZN  A 302 (-3.1A)
ZN  A 302 (-3.1A)
 0.14A 3ljgA-4q1lA:
11.3		 3ljgA-4q1lA:
24.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qhi UNCHARACTERIZED
PROTEIN MJ1213

(Methanocaldococcus
jannaschii) 		PF01435
(Peptidase_M48) 		4 HIS A  69
GLU A  70
HIS A  73
HIS A  80
 ZN  A 201 ( 3.2A)
GOL  A 202 (-3.1A)
ZN  A 201 ( 3.1A)
ZN  A 201 ( 3.2A)
 0.37A 3ljgA-4qhiA:
5.9		 3ljgA-4qhiA:
19.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wk7 A DISINTEGRIN AND
METALLOPROTEINASE
WITH THROMBOSPONDIN
MOTIFS 4

(Homo sapiens) 		PF01421
(Reprolysin) 		4 HIS A 361
GLU A 362
HIS A 365
HIS A 371
 ZN  A 501 ( 3.2A)
3PQ  A 505 (-2.6A)
ZN  A 501 ( 3.3A)
ZN  A 501 ( 3.2A)
 0.22A 3ljgA-4wk7A:
11.0		 3ljgA-4wk7A:
19.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4xct MATRIX
METALLOPROTEINASE-9,
MATRIX
METALLOPROTEINASE-9

(Homo sapiens) 		PF00413
(Peptidase_M10) 		4 HIS A 226
GLU A 227
HIS A 230
HIS A 236
 ZN  A 302 ( 3.2A)
N73  A 301 (-2.5A)
ZN  A 302 ( 3.3A)
ZN  A 302 ( 3.3A)
 0.14A 3ljgA-4xctA:
29.3		 3ljgA-4xctA:
50.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xkm XYLOSE ISOMERASE

(Bacteroides
thetaiotaomicron) 		no annotation 4 ILE A 253
HIS A 279
GLU A 284
HIS A 283
 None
 0.99A 3ljgA-4xkmA:
undetectable		 3ljgA-4xkmA:
15.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4z11 AURONE SYNTHASE

(Coreopsis
grandiflora) 		PF00264
(Tyrosinase)
PF12142
(PPO1_DWL)
PF12143
(PPO1_KFDV) 		4 ILE A 115
HIS A 252
HIS A 256
HIS A 286
 None
CU  A 701 (-3.1A)
CU  A 701 (-3.1A)
CU  A 701 (-3.1A)
 1.03A 3ljgA-4z11A:
undetectable		 3ljgA-4z11A:
15.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5avp L-RIBOSE ISOMERASE

(Geodermatophilus
obscurus) 		no annotation 4 ILE A  69
HIS A 110
HIS A 192
HIS A 112
 None
MN  A 401 (-3.4A)
MN  A 401 (-3.5A)
MN  A 401 (-3.5A)
 0.98A 3ljgA-5avpA:
undetectable		 3ljgA-5avpA:
18.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5czw MYROILYSIN

(Myroides
profundi) 		PF01400
(Astacin) 		4 HIS A 142
GLU A 143
HIS A 146
HIS A 152
 ZN  A 301 ( 3.4A)
ZN  A 301 ( 4.2A)
ZN  A 301 ( 3.3A)
ZN  A 301 ( 3.1A)
 0.36A 3ljgA-5czwA:
11.5		 3ljgA-5czwA:
19.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5d7w SERRALYSIN

(Serratia
marcescens) 		PF00353
(HemolysinCabind)
PF00413
(Peptidase_M10)
PF08548
(Peptidase_M10_C) 		4 HIS A 176
GLU A 177
HIS A 180
HIS A 186
 HIS  A 176 (-1.0A)
GLU  A 177 ( 0.6A)
HIS  A 180 (-1.0A)
HIS  A 186 (-1.0A)
 0.34A 3ljgA-5d7wA:
14.3		 3ljgA-5d7wA:
26.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5h0u MATRIX
METALLOPROTEINASE-14

(Homo sapiens) 		PF00413
(Peptidase_M10) 		4 HIS A 239
GLU A 240
HIS A 243
HIS A 249
 ZN  A 302 ( 3.3A)
GOL  A 311 (-4.2A)
ZN  A 302 (-3.4A)
ZN  A 302 (-3.2A)
 0.16A 3ljgA-5h0uA:
28.0		 3ljgA-5h0uA:
50.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5jig UBIQUITIN AND WLM
DOMAIN-CONTAINING
METALLOPROTEASE
SPCC1442.07C

(Schizosaccharomyces
pombe) 		PF08325
(WLM) 		4 HIS A  97
GLU A  98
HIS A 101
HIS A 107
 NI  A 201 ( 3.3A)
OXY  A 202 (-2.8A)
NI  A 201 ( 3.3A)
NI  A 201 (-3.3A)
 0.30A 3ljgA-5jigA:
3.3		 3ljgA-5jigA:
22.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5lxg ADIPONECTIN RECEPTOR
PROTEIN 1

(Homo sapiens) 		PF03006
(HlyIII) 		4 ILE A 212
HIS A 341
HIS A 337
HIS A 191
 None
ZN  A 401 (-3.2A)
ZN  A 401 (-3.5A)
ZN  A 401 (-3.5A)
 1.01A 3ljgA-5lxgA:
undetectable		 3ljgA-5lxgA:
16.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5n4l CERULOPLASMIN

(Rattus
norvegicus) 		no annotation 4 ILE A 158
HIS A 162
HIS A 974
HIS A1014
 None
CU  A1101 (-3.3A)
CU  A1101 ( 3.2A)
CU  A1101 (-3.2A)
 0.95A 3ljgA-5n4lA:
undetectable		 3ljgA-5n4lA:
19.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5nhb XYLOSE ISOMERASE

(Piromyces sp.
E2) 		no annotation 4 ILE A 252
HIS A 278
GLU A 283
HIS A 282
 None
 1.02A 3ljgA-5nhbA:
undetectable		 3ljgA-5nhbA:
16.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5or4 CATECHOL OXIDASE

(Aspergillus
oryzae) 		no annotation 4 ILE A 109
HIS A 284
HIS A 288
HIS A 312
 None
CU  A2002 (-3.2A)
CU  A2002 (-3.2A)
CU  A2002 (-3.1A)
 0.95A 3ljgA-5or4A:
undetectable		 3ljgA-5or4A:
17.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tem 4-HYDROXY-TETRAHYDRO
DIPICOLINATE
REDUCTASE

(Vibrio
vulnificus) 		no annotation 4 ILE C 168
HIS C 216
GLU C 153
HIS C 155
 None
None
None
PDC  C1002 ( 4.4A)
 0.98A 3ljgA-5temC:
2.7		 3ljgA-5temC:
18.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5th6 MATRIX
METALLOPROTEINASE-9,
MATRIX
METALLOPROTEINASE-9

(Homo sapiens) 		PF00413
(Peptidase_M10)
PF01471
(PG_binding_1) 		4 HIS A 401
GLU A 402
HIS A 405
HIS A 411
 ZN  A 501 (-3.3A)
ZN  A 501 ( 4.2A)
ZN  A 501 (-3.2A)
ZN  A 501 (-3.1A)
 0.23A 3ljgA-5th6A:
24.8		 3ljgA-5th6A:
35.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xbn WSS1P

(Saccharomyces
cerevisiae) 		no annotation 4 HIS A 115
GLU A 116
HIS A 119
HIS A 125
 ZN  A 201 (-3.2A)
ZN  A 201 ( 4.7A)
ZN  A 201 (-3.3A)
ZN  A 201 (-3.2A)
 0.21A 3ljgA-5xbnA:
3.8		 3ljgA-5xbnA:
17.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xne -

(-) 		no annotation 4 HIS B 193
GLU B  62
HIS B 204
HIS B 191
 ZN  B 301 (-3.4A)
ZN  B 301 ( 4.5A)
ZN  B 301 (-3.3A)
ZN  B 301 (-3.5A)
 0.76A 3ljgA-5xneB:
undetectable		 3ljgA-5xneB:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5zhz PROBABLE
ENDONUCLEASE 4

(Mycobacterium
tuberculosis) 		no annotation 4 ILE A 231
HIS A 165
GLU A 129
HIS A 206
 None
ZN  A 306 ( 3.2A)
ZN  A 304 (-2.3A)
ZN  A 306 ( 3.2A)
 1.03A 3ljgA-5zhzA:
undetectable		 3ljgA-5zhzA:
19.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6bdz DISINTEGRIN AND
METALLOPROTEINASE
DOMAIN-CONTAINING
PROTEIN 10

(Homo sapiens) 		no annotation 4 HIS A 383
GLU A 384
HIS A 387
HIS A 393
 ZN  A 705 (-3.3A)
ZN  A 705 (-3.8A)
ZN  A 705 (-4.0A)
ZN  A 705 (-3.2A)
 0.51A 3ljgA-6bdzA:
10.2		 3ljgA-6bdzA:
19.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6btp -

(-) 		no annotation 4 HIS A  93
GLU A  94
HIS A  97
HIS A 103
 ZN  A 302 ( 3.3A)
E8J  A 304 (-2.6A)
ZN  A 302 ( 3.4A)
ZN  A 302 ( 3.3A)
 0.14A 3ljgA-6btpA:
10.1		 3ljgA-6btpA:
undetectable